Interview: Enthought - the trials and tribulations of AI

OSP had a great conversation with Mike Connell, chief operating officer, at Enthought. The discussion centered around aritificial intelligence (AI) which have been the buzzwords in pharma and a number of other industries for at least the last year.

Related Keywords

,President Biden ,Contract Manufacturing Amp Logistics ,Drug Delivery ,Clinical Development ,Atient Centricity ,Linical Evolution ,Delivery Technologies ,Processing Equipment ,Regulations ,Hi ,Artificial Intelligence ,Data Management ,Machine Learning ,Research ,Drug Discovery ,